Dec 15, 2025
12 Consumer Discretionary Stocks Moving In Monday’s Intraday Session

Gainers Netclass Technology (NASDAQ:NTCL) shares rose 32.6% to $0.9 during Monday's regular session. The market value of their outstanding shares is at $14.9 million. 1-800-Flowers.com (NASDAQ:FLWS) stock increased by 14.45% to $4.47. The company's market cap stands at $248.9 million.…

Dec 15, 2025
What’s Driving The Sell-Off In Luminar Technologies (LAZR) Stock?

Luminar Technologies, Inc. (NASDAQ:LAZR) shares are under heavy pressure Monday after the company announced that it initiated voluntary Chapter 11 proceedings to pursue court-supervised sale processes for its core businesses. Luminar Technologies shares are approaching critical lows. What’s pressuring LAZR? What To Know:…

Dec 15, 2025
Behind the Scenes of Carvana’s Latest Options Trends

Deep-pocketed investors have adopted a bullish approach towards Carvana (NYSE:CVNA), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a…

Dec 15, 2025
A Look Into AppLovin Inc’s Price Over Earnings

In the current session, the stock is trading at $683.87, after a 1.97% increase. Over the past month, AppLovin Inc. (NASDAQ:APP) stock increased by 30.01%, and in the past year, by 102.39%. With performance like this, long-term shareholders are optimistic…

Dec 15, 2025
Why Is Radiopharm Theranostics Stock Rallying Over 140%?

Radiopharm Theranostics Limited (NASDAQ:RADX) stock is trading higher on Monday, with a session volume of 21.33 million compared to the average volume of 26.81 thousand, as per data from Benzinga Pro. On Monday, Radiopharm Theranostics shared interim data from the…

Dec 15, 2025
CrowdStrike Says AI Prompts Are The New Malware

CrowdStrike Holdings, Inc. (NASDAQ:CRWD) on Monday announced the general availability of Falcon AI Detection and Response (AIDR), expanding its Falcon platform to address what the company describes as the fastest-growing AI attack surface: the AI prompt and agent interaction layer.…

Dec 15, 2025
Palvella: 73% Improved In Phase 2 Study Of Skin Condition Treatment

Palvella Therapeutics, Inc. (NASDAQ:PVLA) on Monday shared topline results from its Phase 2 TOIVA study of QTORIN 3.9% rapamycin anhydrous gel (QTORIN rapamycin) for cutaneous venous malformations (cutaneous VMs). Cutaneous venous malformations are common, benign, slow-flow vascular anomalies appearing as…